BANK VONTOBEL/PUT/ELI LILLY & CO/700/0.1/20.09.24 Share Price

Warrant

DE000VM9ZDK9

Market Closed - Deutsche Boerse AG 19:01:55 28/06/2024 BST
0.27 EUR -15.62% Intraday chart for BANK VONTOBEL/PUT/ELI LILLY & CO/700/0.1/20.09.24
Current month-78.91%
1 month-81.12%
Date Price Change
28/06/24 0.27 -15.62%
27/06/24 0.32 -5.88%
26/06/24 0.34 +6.25%
25/06/24 0.32 -8.57%
24/06/24 0.35 -16.67%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 07:01 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer Vontobel Vontobel
WKN VM9ZDK
ISINDE000VM9ZDK9
Date issued 07/02/2024
Strike 700 $
Maturity 20/09/2024 (83 Days)
Parity 10 : 1
Emission price 5.07
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 4.58
Lowest since issue 0.26
Delta-0.05x
Omega 13.54
Premium23.03x
Gearing291.5x
Moneyness 0.7732
Difference Strike -205.4 $
Difference Strike %-29.34%
Spread 0.02
Spread %6.67%
Intrinsic value 0.000000

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
905.4 USD
Average target price
868.9 USD
Spread / Average Target
-4.03%
Consensus